ITGB3 and stroke disorder: Notwithstanding, after 7 days of the onset of stroke, intravenous thrombolysis (IVT)-treated patients (n = 10) had 59% less platelet-originated cMPs (CD61+/AV+ cMPs, P = 0.014).